serena williams glp-1 husband discusses use as a Ro celebrity ambassador Serena Williams has officially entered

denied Novo Nordisk's attempt to dismiss Jaclyn Bjorklund's case

Now we have developed a new type of weight-loss drug that affects the plasticity of the brain and appears to be highly effective, says Clemmensen, from the Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen and senior author of the study

Originally designed for managing type 2 diabetes, these medications have gained attention for their ability to support weight loss

Though the medication was originally developed as a diabetes drug, its been shown to be effective for a myriad of conditions, like polycystic ovarian syndrome and migraines

This approach reflects a broader trend in healthcare, where financialization drives profit maximization at the expense of equity and accessibility